Natera, Inc.
NTRA- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001604821
In the last 90 days, Natera, Inc. insiders filed 0 open-market purchases and 30 sales; 850 institutions reported holding it in 13F filings for Q2 2026, worth $37.2B in total; 5 superinvestors hold it, including Duquesne Family Office and Coatue Management.
Holders of 5% or more of NTRA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Natera, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| JPMorgan Chase & Co | 13G/A | 9.10%12.8M shares | +1.40 ppfrom 7.70% | Feb 10, 20253 filings | Jan 23, 2026 | SEC |
| Price T Rowe Associates Inc | 13G/A | 6.30%9.02M shares | −1.50 ppfrom 7.80% | Feb 14, 20255 filings | Aug 14, 2026 | SEC |
| BlackRock, Inc. | 13G/A | 5.60%7.57M shares | – | Apr 17, 20251 filing | Apr 17, 2025 | SEC |
| Vanguard Capital Management LLC | 13G | 5.08%7.21M shares | New | Apr 30, 20261 filing | Apr 30, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
11 Schedule 13D and 13G filings on Natera, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 202610:38 AM ET | Price T Rowe Associates Inc | 13G/A | 6.30%9.02M shares | −1.50 ppfrom 7.80% | Jun 30, 2026 | SEC |
| Apr 30, 202611:29 AM ET | Vanguard Capital Management LLC | 13G | 5.08%7.21M shares | New | Mar 31, 2026 | SEC |
| Mar 27, 202610:52 AM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Feb 17, 202610:26 AM ET | Price T Rowe Associates Inc | 13G/A | 7.80%10.9M shares | −1.10 ppfrom 8.90% | Dec 31, 2025 | SEC |
| Jan 23, 202611:08 AM ET | JPMorgan Chase & Co | 13G/A | 9.10%12.8M shares | +1.40 ppfrom 7.70% | Dec 31, 2025 | SEC |
| Aug 14, 20251:07 PM ET | Price T Rowe Associates Inc | 13G/A | 8.90%12.2M shares | +1.10 ppfrom 7.80% | Jun 30, 2025 | SEC |
| Jul 22, 20251:51 PM ET | JPMorgan Chase & Co | 13G/A | 7.70%10.6M shares | +2.70 ppfrom 5.00% | Jun 30, 2025 | SEC |
| May 14, 202510:45 AM ET | Price T Rowe Associates Inc | 13G/A | 7.80%10.6M shares | +2.70 ppfrom 5.10% | Mar 31, 2025 | SEC |
| Apr 17, 20259:35 AM ET | BlackRock, Inc. | 13G/A | 5.60%7.57M shares | – | Mar 31, 2025 | SEC |
| Feb 14, 20259:44 AM ET | Price T Rowe Associates Inc | 13G | 5.10%6.74M shares | New | Dec 31, 2024 | SEC |
| Feb 10, 202512:51 PM ET | JPMorgan Chase & Co | 13G | 5.00%6.67M shares | New | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Natera, Inc. shares.
No Form 144 notices for Natera, Inc. are on file.